Early-stage biotech developing gene therapy for spinal muscular atrophy.
Industry: Health Care
First Day Return: -9.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/15/2016 |
Offer Price | $20.00 |
Price Range $19.00 - $21.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $95 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/10/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $95 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Bannockburn, IL, United States |
Founded | 2010 |
Employees at IPO | 18 |
Website www.avexis.com |